Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand

Coxsackievirus B3 (CVB3) is the most common causal agent of viral myocarditis, but existing drug therapies are of limited value. Application of small interfering RNA (siRNA) in knockdown of gene expression is an emerging technology in antiviral gene therapy. To investigate whether RNA interference (...

Cijeli opis

Bibliografski detalji

Izdano u:	J Virol
Glavni autori:	Yuan, Ji, Cheung, Paul K. M., Zhang, Huifang M., Chau, David, Yang, Decheng
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2005
Teme:	Vaccines and Antiviral Agents
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC546545/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15681418/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.79.4.2151-2159.2005
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!